Philadelphia, PENNSYLVANIA3 Active Studies

Liver Cancer Clinical Trials in Philadelphia, PENNSYLVANIA

Find 3 actively recruiting liver cancer clinical trials in Philadelphia, PENNSYLVANIA. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
195
Enrolling

Recruiting Liver Cancer Studies in Philadelphia

About Liver Cancer Clinical Trials in Philadelphia

Liver cancer most commonly presents as hepatocellular carcinoma (HCC) and is often associated with chronic liver disease or hepatitis. It is one of the fastest-growing causes of cancer death. Treatment options include surgery, liver transplant, ablation, and systemic therapies.

There are currently 3 liver cancer clinical trials recruiting participants in Philadelphia, PENNSYLVANIA. These studies are seeking a combined 195 participants. Research is being sponsored by Cogent Biosciences, Inc., Replimune Inc., Teclison Ltd.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Liver Cancer Clinical Trials in Philadelphia — FAQ

Are there liver cancer clinical trials in Philadelphia?

Yes, there are 3 liver cancer clinical trials currently recruiting in Philadelphia, PENNSYLVANIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Philadelphia?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.

Are clinical trials in Philadelphia free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.

What liver cancer treatments are being tested?

The 3 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for liver cancer.

Data updated March 2, 2026 from ClinicalTrials.gov